HENOCH-SCHOENLEIN PURPURA

 

HENOCH-SCHOENLEIN PURPURA

 

DEFINITION:

A vasculitic syndrome of small vessels classically characterized by a purpuric rash, abdominal pain, arthritis, and nephritis.

EPIDEMIOLOGY:

  • incidence: most common form of systemic vasculitis in children
  • age of onset:
    • 75% of cases between 2-11 years of age; mean of 5.5 years
    • milder disease in those <2 years
  • risk factors:
    • M > F (1.5-2.0:1)
    • spring and autumn
    • whites > blacks

PATHOGENESIS:

1. Background

  • antigenic stimulant -> elevated IgA levels -> IgA-mediated vasculitis in small vessels of involved organs -> necrotizing vasculitis

2. Antigenic Stimulants

1. Allergens

  • drugs (ampicillin, erythromycin, penicillin, quinidine, quinine)
  • exposure to cold
  • foods
  • horse serum
  • insect bites

2. Post-Infectious

  • bacterial - Hemophillus Parainfluenzae, Mycoplasma, Legionella, Yersinia
  • viral - adenovirus, EBV, parvovirus, varicella

3. Post-Vaccination

  • cholera
  • measles
  • paratyphoid A & B
  • typhoid
  • yellow fever

PATHOLOGY:

1. Mechanism of Vasculitis

  • deposition of IgA-containing immune complexes with subsequent activation of complement leads to a vasculitis
  • biopsy of an acute skin lesion reveals an aseptic vasculitis with fibrinoid necrosis of vessel walls and perivascular cuffing of vessels with PMN's

CLINICAL FEATURES:

1. Classical Features

  • 100% - rash (nonthrombocytopenic purpura)
  • 68% - arthritis
  • 53% - abdominal pain
  • 38% - nephritis

2. Cutaneous Manifestations

1. Classic Rash (100%)

  • presenting feature in 50% of cases

1. Classic Lesion

  • urticarial wheals, erythematous maculopapules and/or larger palpable ecchymotic-looking lesions
  • appear on lower extremities and buttocks
  • may involve upper extremities, face, and trunk

2. Petechiae or Purpura Lesions

  • evolve from red to purple -> rust-coloured with brownish hue -> fade
  • as new crops arise may give a polymorphic appearance
  • may be pruritic

3. Erythema Multiforme

  • various forms - central hemorrhage or ulceration with bullae formation

4. Angioedema

  • of extremities (46%) and scalp (20%)
  • nonpitting involving eyelids, lips, dorsa of hands and feet, back, perineum

5. Others

  • vesicular eruptions
  • swelling and tenderness of an entire limb

3. Rheumatologic Manifestations

1. Arthritis/Arthralgia (68-75%)

  • presenting feature in 25% of cases
  • tends to be periarticular
  • no bleeding or effusion into joints
  • joints swollen, tender, and painful
  • ankles and knees most commonly affected
  • rarely fingers and wrists involved
  • transient but may recur during active disease
  • no permanent deformation

4. Gastrointestinal Manifestations

1. Abdominal Pain (35-85%)

  • 3rd most common presenting complaint
  • severe colicky pain with vomiting
  • usually follows onset of rash and joint pain

2. Bloody Stool

  • gross or occult with hematemesis

3. Intussusception (2-3%)

  • lead point a submucosal hematoma
  • ileoileal in 65% of cases
  • best diagnosed by ultrasound as barium enema may miss

4. Others

  • bowel infarction +/- perforation
  • hepatomegaly
  • hydrops of the gallbladder
  • ileal stricture
  • ileus
  • massive GI bleed
  • pancreatitis

5. Renal Manifestations

  • occur in 20-50% of cases
  • develop within 3 months of the onset of rash but in 3% of cases may precede rash
  • renal involvement more likely with:
    • gastrointestinal involvement
    • persistence of rash for 2-3 months
    • episodic purpura
  • no relationship between the severity of nephritis and severity of extrarenal manifestations
  • complications:
    • persistent nephropathy in 1%
    • end-stage renal disease in <1%

1. Range of Renal Manifestations

1. Hematuria

  • microscopic with proteinuria <2g/d
  • preserved renal function
  • a mild form of renal disease which does not evolve into end-stage renal disease

2. Nephritic Syndrome

  • hematuria with hypertension, azotemia, and oliguria
  • proteinuria
  • 15% develop end-stage renal disease (ESRD)

3. Nephrotic Syndrome

  • urinary protein excretion >40 mg/m2/hr
  • 50% of patients with both nephrotic and nephritic syndromes develop ESRD within 10 years of onset

2. Other GU Manifestations

1. Extrarenal

1. Scrotal Swelling (2-35%)
  • associated with inflammation and hemorrhage of testes, appendix testes, spermatic cord, epi-didymis or scrotal wall
  • true torsion develops rarely

2. Renal

  • bladder wall hematoma
  • calcified ureter
  • hydronephrosis
  • urethritis

6. Neurological Manifestations

1. Central Nervous System (uncommon)

1. Headaches

  • most common CNS symptom

2. Altered Mental Status

  • apathy, hyperactivity, irritability, mood lability, somnolence

3. Seizures

  • partial, complex partial, generalized, status

4. Focal Deficits

  • aphasia, ataxia, chorea, cortical blindness, hemiparesis, paraparesis, quadriparesis

2. Peripheral Nervous System (rare)

1. Polyradiculoneuropathies

  • brachial plexus neuropathy, Guillian-Barre syndrome

2. Mononeuropathies

  • facial nerve, femoral nerve, peroneal nerve, sciatic nerve, ulnar nerve

7. Hematologic Manifestations

1. Hemorrhagic Diathesis

  • associated with a coagulopathy
  • Factor VIII and/or vitamin K deficiencies
  • hypoprothrombinemia
  • pulmonary hemorrhage -> hemoptysis
  • hemorrhage into large muscle groups -> pain

INVESTIGATIONS:

1. Serum

  • CBC - thrombocytosis in 67% of cases, leukocytosis with L shift
  • lytes, BUN, creatinine, albumin, amylase, liver function tests
  • ESR mildly elevated in 75% of cases
  • PT, PTT - hypoprothrombinemia
  • Factors VIII and XIII - decreased
  • serum IgA levels - elevated in 50% of cases
  • ASO titre - elevated in 30% of cases
  • CH50 - decreased in 30% of cases
  • C3, C4 - occasionally low
  • CIC (IgG & IgA) - increased

2. Urinalysis

  • hematuria, proteinuria
  • microscope - glomerular pattern - damaged RBC's and RBC casts
  • perform monthly x 3

3. Imaging Studies

  • abdominal x-ray, ultrasound, CT
  • barium enema
  • chest x-ray - pulmonary hemorrhage
  • testicular ultrasound

4. Biopsies

1. Skin

  • of purpuric lesions show leukocytoclastic vasculitis with
  • IgA deposits

2. Renal

  • LM - diffuse hypercellularity
    • focal and segmental proliferation
    • mesangial proliferation
  • minimal change to severe cresentric GN
  • segmental sclerosis, fibrosis, mononuclear cell infiltration
  • EM - mesangial, subendothelial, & subepithelial deposits
  • IFM - diffuse glomerular deposits of IgA, C3, fibrin, IgG, properdin and IgM
  • IgA deposits in the mesangium:
  • % of Glomeruli with Cresents (Frequency of Renal Failure)
  • <50 (4%)
  • 50-75 (25%)
  • >75 (67%)
  • 100 (100%)

MANAGEMENT:

Renal Failure

1. Supportive

1. Acute

  • adequate hydration
  • discontinue any exposure to antigenic stimulants, i.e., drugs

2. Long Term

  • weekly follow-up for first month, every 2nd week for the second month, and at the end of the 3rd month monitering

1. Clinical

  • cutaneous, rheumatoid, gastrointestinal, renal, and neurological manifestations

2. Investigations

  • CBC, electrolytes, BUN, creatinine, albumin, amylase, urinalysis, stool for occult blood
  • seek immediate medical attention for
    • sudden onset of severe abdominal pain, distension, or bleeding
    • hemoptysis (breathing up blood)
    • seizures, personality changes, focal deficits, peripheral neuropathies

2. Medications

1. NSAID's

  • for joint and soft tissue pain

2. Corticosteroids

1. Prednisone

  • 1-2 mg/kg/day for 5-7 days
  • indications:
    • greater than 50% cresents on renal biopsy
    • abdominal colic or GI hemorrhage
    • soft tissue swelling
    • scrotal swelling
    • neurologic manifestations
    • intrapulmonary hemorrhage
  • not recommended for:
    • rash
    • joint pain

3. Nephropathy

1. Supportive

  • fluid & electrolyte balance, moniter salt intake
  • antihypertensives

2. Experimental

  • immunosuppressive drugs, i.e., azathioprine (Imuran)
  • plasmaphoresis

4. Prognosis

1. Excellent

  • if no renal or neurologic manifestations or microscopic hematuria
  • lasts 4-6 weeks in a majority of cases
  • recurrences in 50% within 6 weeks but as late as 7 years
  • children <3 years have a shorter, milder course with fewer recurrences

2. Poor

  • associated with renal manifestations
  • progression to ESRF may not occur for years
  • end-stage renal failure associated with:
    • HSP nephritis in children >6 yrs of age
    • development of nephrotic syndrome
    • crescent formation in >50% of glomeruli

 

 

Pediatric Database - HENOCH-SCHOENLEIN PURPURA

Pediatric Organization - Pedbase [at] Gmail.com